Chiba

The trials here

What the trial at this site is about, from its registry record.

Conditions

• CIDP (chronic inflammatory demyelinating polyneuropathy)

Running trials

• Active, not recruiting

  A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)

  NCT04280718· Phase 2· argenx· Source